| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.08T | 13.70T | 13.37T | 13.14T | 12.16T | 11.94T |
| Gross Profit | 2.14T | 2.39T | 2.63T | 2.50T | 2.46T | 2.36T |
| EBITDA | 3.55T | 3.42T | 3.70T | 3.46T | 3.39T | 3.20T |
| Net Income | 1.08T | 1.00T | 1.28T | 1.21T | 1.18T | 916.18B |
Balance Sheet | ||||||
| Total Assets | 46.83T | 30.93T | 30.43T | 25.76T | 23.86T | 22.97T |
| Cash, Cash Equivalents and Short-Term Investments | 2.82T | 1.61T | 1.05T | 859.65B | 888.65B | 965.09B |
| Total Debt | 18.23T | 11.29T | 10.71T | 9.15T | 8.21T | 8.37T |
| Total Liabilities | 36.85T | 19.59T | 19.54T | 16.41T | 14.84T | 14.76T |
| Stockholders Equity | 9.51T | 10.22T | 9.84T | 8.56T | 8.28T | 7.56T |
Cash Flow | ||||||
| Free Cash Flow | -14.65B | 231.74B | 290.15B | 409.13B | 1.25T | 1.21T |
| Operating Cash Flow | 2.24T | 2.36T | 2.37T | 2.26T | 3.01T | 3.01T |
| Investing Cash Flow | -3.33T | -2.01T | -1.99T | -1.74T | -1.70T | -1.42T |
| Financing Cash Flow | 2.70T | -328.64B | -234.45B | -590.20B | -1.44T | -1.69T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥327.59B | 18.43 | 13.42% | 2.27% | 5.10% | 12.48% | |
66 Neutral | ¥10.23T | 16.09 | 13.75% | 2.85% | 3.34% | 20.36% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥441.56B | 19.63 | 15.67% | 1.31% | 12.48% | 18.38% | |
60 Neutral | ¥10.49T | 19.08 | ― | 3.99% | 7.79% | 5.53% | |
56 Neutral | ¥13.42T | 9.80 | 11.22% | 3.36% | 2.10% | -9.29% | |
56 Neutral | ¥295.69B | 24.87 | 17.97% | 1.36% | 4.75% | 17.02% |